Buy or sell DNAnexus stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
DNAnexus Stock
Cloud-based genome informatics and data management platform
About DNAnexus Stock
DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomic medicine. DNAnexus provides security, scalability and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health.
Investors
Claremont Creek Ventures
Felicis Ventures
Wish, Opendoor, Dollar Shave Club, Scopely, Guardant Health, Fitbit, Plaid, Jam City, Adyen, Chegg
First Round Capital
Flexport, AppNexus, Blue Apron, Clover Health, Fab, Roblox, Earnest, Warby Parker, Boxed, LendingHome
Microsoft
Pivotal, Impossible Foods, Databricks, Adaptive Biotechnologies, ClearMotion, SnapLogic, DNAnexus, Foursquare, Xant, Synack
MidCap Financial
TPG Biotech
Funding History
| August 2009 | $1.6M |
|---|---|
| October 2011 | $15.0M |
| January 2014 | $15.0M |
| April 2015 | $15.0M |
| January 2018 | $58.0M |
| February 2019 | $68.0M |
Management
Chief Executive Officer
Richard Daly
Chief Technology Officer
George Asimenos
Chief Product Officer
John Ellithorpe
Chief Financial Officer
Scott Gibson
Chief Cloud Officer
Omar Serang
Chief Revenue Officer
Mark Swendsen
Press
GeNomeWeb - Dec, 18 2019
Business Wire - Dec, 3 2019
Business Wire - Mar, 11 2019
Business Wire - Feb, 6 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from DNAnexus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
